- Release Date: 18/06/13 17:52
- Summary: S/HOLDER: EBO: EBOS Share Entitlement - Reminder Letter Action Required
- Price Sensitive: No
- Download Document 2.85KB
EBO 18/06/2013 15:52 S/HOLDER REL: 1552 HRS Ebos Group Limited S/HOLDER: EBO: EBOS Share Entitlement - Reminder Letter Action Required 17 June 2013 Dear Shareholder, EBOS Share Entitlement - Action Required At a Special Meeting held in Christchurch last Friday (14 June 2013), Shareholders voted overwhelmingly to approve the acquisition by EBOS Group Limited of Zuellig Healthcare Holdings Australia Pty Limited ("Symbion"). The acquisition will establish EBOS as Australasia's leading supply and distribution platform for pharmaceutical products in both Australia and New Zealand by revenue, with a diversified Australasian animal care offering. As part of the financing of this acquisition, EBOS announced an underwritten entitlement offer to all eligible shareholders on 29 May 2013. You will have received a letter detailing your Entitlement to subscribe for New Shares along with a copy of the Offer Document for the Entitlement Offer. If you have not received details of your Entitlement or the Offer Document, please immediately call Computershare information hotline on 0800 835 625 (within New Zealand). IT IS VERY IMPORTANT THAT ALL SHAREHOLDERS TAKE ACTION REGARDING THE ENTITLEMENT OFFER. EITHER: - TAKE UP YOUR ENTITLEMENT TO SUBCRIBE FOR NEW SHARES by 1 July 2013 - OR SELL YOUR ENTITLEMENT TO THE NEW SHARES by 25 June 2013 if you wish to sell some or all of your Entitlements on the NZX Main Board Although the Closing Date is 1 July 2013, EBOS encourages Shareholders wishing to accept the Entitlement Offer to do so promptly, to ensure your application is processed and your payment cleared. EBOS encourages you to make payment by direct credit. DOING NOTHING MEANS YOU ARE LIKELY TO LOSE VALUE ACT NOW! We encourage you to read the Offer Document carefully before making your investment decision. Section 5 "Details of the Offer and Answers to Important Questions" on pages 9-12 of the Offer Document and section 14 "What You Need To Do Next" on page 60 explains the actions required. If you are unsure what to do, we strongly recommend you contact your investment adviser or call the Computershare information hotline on 0800 835 625 (within New Zealand). If you were a registered Shareholder at 5pm on 14 June 2013 and your address in the EBOS share register is in New Zealand or Australia, you are an Eligible Shareholder for the Entitlement Offer. If you accept your Entitlement in full and your registered address is in New Zealand, you are also entitled to apply for Additional New Shares through the Oversubscription Facility described in the Offer Document. The Board is confident that the addition of Symbion will bring further diversification to the EBOS business and opportunities for further earnings growth. Thank you for your support. Yours sincerely, Dennis Doherty Chief Financial Officer End CA:00237557 For:EBO Type:S/HOLDER Time:2013-06-18 15:52:30
- Forums
- NZX - By Stock
- Ann: S/HOLDER: EBO: EBOS Share Entitlement - Remi
Ann: S/HOLDER: EBO: EBOS Share Entitlement - Remi
Featured News
Add EBO (NZSX) to my watchlist
|
|||||
Last
$35.00 |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
$35.01 | $35.39 | $35.00 | $8.069M | 230.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
0 | 3 | $34.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$35.19 | 400 | 0 |
Last trade - 13.00pm 30/08/2024 (20 minute delay) ? |
Featured News
EBO (NZSX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online